Selected article for: "China coronavirus disease and control prevention"
Author: Qu, Jie-Ming; Wang, Chen; Cao, Bin
Title: Guidance for the management of adult patients with coronavirus disease 2019
  • Cord-id: 3lck1a0w
  • Document date: 2020_7_5
    • ID: 3lck1a0w
    Snippet: In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the ava
    Document: In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.

    Search related documents:
    Co phrase search for related documents
    • abnormal coagulation and acute phase: 1, 2
    • abnormal coagulation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • abnormal coagulation and liver enzyme: 1
    • abnormal coagulation and lopinavir ritonavir: 1
    • abnormal coagulation and lopinavir ritonavir combination: 1
    • abnormal coagulation and lung disease: 1, 2
    • abnormal coagulation and lung injury: 1, 2, 3, 4, 5
    • abnormal coagulation and lung tissue: 1
    • abnormal coagulation and lymphocyte count: 1, 2
    • abnormal coagulation and macrophage activation: 1, 2, 3
    • abnormal coagulation and macrophage activation syndrome: 1, 2, 3
    • abroad home and acute respiratory syndrome: 1